GoodRx Holdings, Inc. GDRX
Set alert
3.55 USD +0.06 +1.72%
At close
3.53 -0.02 -0.56%
Pre-market · Nov 3, 5:24 AM ET
3.50 Day range 3.64
1.77 52-week range 3.89
- YTD
- +31.00%
- 1 year
- +7.25%
- Open
- 3.49
- Prev close
- 3.49
- Mkt cap
- 1.21B
- Vol
- 1.17M
- Avg vol
- 1.30M
- EPS
- 0.05
- P/E
- 71.00
- Div yield
- 0.00%
More statistics
- Low
- 3.50
- High
- 3.64
- Forward P/E
- 10.08
- Beta
- 1.66
- Short ratio
- 4.43
- Inst. own
- 55.86%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 3, 2026
- 50-d avg
- 3.43
- 200-d avg
- 2.82
- 1y target
- 3.95
Analyst view
Consensus: hold
Hold
Price target (mean) 3.95 +11.3% upside
Now 3.55
- Target (low)
- 2.65
- Target (mean)
- 3.95
- Target (high)
- 5.00
Ratings (0m) 14 4 buy · 8 hold · 2 sell
- Strong buy1
- Buy3
- Hold8
- Sell0
- Strong sell2
Recommendation trend
- This month 14
- 1 month ago 14
- 2 months ago 15
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.07787 | 0.07 – 0.10 | 0.08 | -2.7% | 202.09M | +3.1% | 11 |
| Next quarter | 0.07944 | 0.07 – 0.10 | 0.09 | -11.7% | 202.09M | +3.8% | 11 |
| Current year | 0.30303 | 0.28527 – 0.34 | 0.35 | -13.4% | 798.48M | +0.2% | 11 |
| Next year | 0.35203 | 0.301 – 0.45 | 0.30303 | +16.2% | 836.21M | +4.7% | 11 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 21, 2026 | Barclays | Maintained | Underweight | Underweight |
| Aug 13, 2026 | UBS | Maintained | Neutral | Neutral |
| Aug 11, 2026 | Citigroup | Maintained | Buy | Buy |
| Aug 11, 2026 | TD Cowen | Maintained | Buy | Buy |
| Aug 7, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| May 14, 2026 | Citigroup | Maintained | Buy | Buy |
| May 11, 2026 | TD Cowen | Maintained | Buy | Buy |
| Mar 4, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Mar 3, 2026 | Citigroup | Maintained | Buy | Buy |
| Mar 2, 2026 | Goldman Sachs | Maintained | Neutral | Neutral |
| Feb 27, 2026 | Mizuho | Maintained | Neutral | Neutral |
| Feb 27, 2026 | JP Morgan | Downgrade | Overweight | Neutral |
| Jan 22, 2026 | Jefferies | Downgrade | Buy | Hold |
| Jan 9, 2026 | Citigroup | Maintained | Buy | Buy |
| Dec 18, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Dec 9, 2025 | Barclays | Initiated | — | Underweight |
| Nov 11, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Nov 10, 2025 | TD Cowen | Maintained | Buy | Buy |
| Nov 6, 2025 | UBS | Maintained | Neutral | Neutral |
| Nov 6, 2025 | Mizuho | Maintained | Neutral | Neutral |
| Aug 11, 2025 | UBS | Maintained | Neutral | Neutral |
| May 13, 2025 | UBS | Maintained | Neutral | Neutral |
| May 9, 2025 | Goldman Sachs | Maintained | Neutral | Neutral |
| Apr 29, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Apr 10, 2025 | Truist Securities | Maintained | Hold | Hold |
| Feb 28, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Jan 10, 2025 | Citigroup | Maintained | Buy | Buy |
| Jan 8, 2025 | Keybanc | Maintained | Overweight | Overweight |
| Dec 17, 2024 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Nov 13, 2024 | Citigroup | Maintained | Buy | Buy |
